Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-056787

Chief Financial Officer sold 12,771 shares at an average $79.13 ($1,010,506)

  • Chief Financial Officer acquired 12,771 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GARCIA PETER S · Chief Financial Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-16 Exercise or conversion : show line 1 in the form +1,426 $4.08 $5,818 10,757 D
2021-09-16 Sale : show line 2 in the form −1,426 $80.43 $114,695 9,331 D
2021-09-17 Exercise or conversion : show line 3 in the form +11,345 $4.08 $46,288 20,676 D
2021-09-17 Sale : show line 4 in the form −1,027 $77.84 $79,944 19,649 D
2021-09-17 Sale : show line 5 in the form −7,199 $78.61 $565,922 12,450 D
2021-09-17 Sale : show line 6 in the form −1,746 $79.46 $138,734 10,704 D
2021-09-17 Sale : show line 7 in the form −273 $80.22 $21,901 10,431 D
2021-09-17 Sale : show line 8 in the form −1,100 $81.19 $89,309 9,331 D
Open-market sales · 12,771 sh · avg $79.13 · $1,010,506

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-16 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −1,426 79,042 D
2021-09-17 Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) −11,345 67,697 D
Loading xslF345X03/doc4.xml…